The Symptoms of Narcolepsy Providers Miss: Why Diagnostic Delay Remains Years Long

A clinical review for primary care, psychiatry, neurology, and pediatric providers The Scope of the Problem Narcolepsy is not a rare diagnosis because the disease is rare. It is a rare diagnosis because it is rarely recognized in time. The condition affects roughly 1 in 2,000 people, yet the average time from symptom onset to… Continue reading →

Chronic Insomnia

Def: difficulty falling or maintaining sleep for atleast 3 times a week for atleast 3 months. Provided other sleep disorders are ruled out.Prevelance; atleast 6-10% of adults, mostly women Subtypes of Chronic Insomnia1. Psychophysiological – racing thoughts, heightened arousals, anxiety 2. Paradoxical Insomnia – perception of not sleeping, when all objective data says otherwise3. Insomnia… Continue reading →

In adults being evaluated for a sleep disorder, how does data from a consumer smart ring compare with laboratory polysomnography for accuracy in sleep staging and detection of sleep-disordered breathing?

Clinical answer: Smart rings are reasonably accurate for basic sleep-wake detection, total sleep time, and sleep efficiency, but they are not accurate enough to diagnose sleep disorders on their own (SOR B). Two-stage sleep-wake detection from rings like Oura approaches near-perfect agreement with PSG. Four-stage staging (light, deep, REM, wake) is weaker, and accuracy drops… Continue reading →

Pantoprazole and Other Proton Pump Inhibitors, Sleep, and Cardiovascular Safety: A Research Breakdown

This is an editorial, not an original study. The authors set out to weigh the evidence for and against a link between proton pump inhibitors (PPIs) and cardiovascular disease. They also raise a pathway that gets little attention in this debate. PPIs affect sleep, and poor sleep is tied to hypertension, metabolic problems, and cardiovascular… Continue reading →

Cognitive Behavior vs Bright Light Therapy for Insomnia in Women Undergoing Chemotherapy for Breast Cancer: A Randomized Clinical Trial

The SleepCARE trial tested whether cognitive behavior therapy for insomnia (CBT-I) and bright light therapy (BLT) reduce insomnia and fatigue symptoms in women having chemotherapy for breast cancer. It also tested whether combining the two works better than either alone. No prior RCT had compared CBT-I and BLT head to head, or tested them together,… Continue reading →